Preprints with The Lancet is part of SSRN´s First Look, a place where journals identify content of interest prior to publication. Authors have opted in at submission to The Lancet family of journals to post their preprints on Preprints with The Lancet. The usual SSRN checks and a Lancet-specific check for appropriateness and transparency have been applied. Preprints available here are not Lancet publications or necessarily under review with a Lancet journal. These preprints are early stage research papers that have not been peer-reviewed. The findings should not be used for clinical or public health decision making and should not be presented to a lay audience without highlighting that they are preliminary and have not been peer-reviewed. For more information on this collaboration, see the comments published in The Lancet about the trial period, and our decision to make this a permanent offering, or visit The Lancet´s FAQ page, and for any feedback please contact firstname.lastname@example.org.
Clinical Findings of Patients with Coronavirus Disease 2019 in Jiangsu Province, China: A Retrospective, Multi-Center Study
33 Pages Posted: 10 Mar 2020More...
Background: Limited data are available for clinical characteristics of patients with coronavirus disease 2019 (COVID-19) outside of Wuhan. This study aimed to describe the clinical characteristics of COVID-19 and identify the risk factors for severe illness of COVID-19 in Jiangsu province, China.
Methods: Clinical data of hospitalized COVID-19 patients were retrospectively collected in ten hospitals from nine cities of Jiangsu province, China. Clinical findings of COVID-19 patients were described and risk factors for severe illness of COVID-19 were analyzed.
Findings: By Feb 10, 2020, 221 hospitalized patients with COVID-19 were enrolled. The median age of patients was 45.0 years (interquartile range, 33.5–56.0). 60 (27.1%) patients had comorbidities. At onset of illness, the common symptoms were fever (171 [77.4%]) and cough (133 [60.2%]). 68 (30.8%) patients had lymphopenia. 211 (95.5%) patients had abnormal radiological findings. 11 (5.0%) patients were admitted to the intensive care unit and none of the patients died. 25 (11.3%) patients had severe illness. Severe illness of COVID-19 was independently associated with body mass index (BMI)≥28 kg/m 2 (odds ratio [OR], 5.872; 95% confidence interval [CI], 1.595 to 21.621; P=0.008) and a known history of type 2 diabetes (OR, 7.033; 95% CI, 1.908 to 25.921; P=0.003).
Interpretation: In this case series in Jiangsu Province, COVID-19 patients have less severe symptoms and have better outcomes than the initial COVID-19 patients in Wuhan. The BMI ≥ 28 kg/m 2 and a known history of type 2 diabetes are independent risk factors of severe illness in patients with COVID-19.
Funding Statement: None.
Declaration of Interests: All authors declare no competing interests.
Ethics Approval Statement: The study was approved by the institutional ethics board of these hospitals, with a waiver of informed consent.
Suggested Citation: Suggested Citation